157 related articles for article (PubMed ID: 2736212)
1. The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases.
Koscielny S; Le MG; Tubiana M
Br J Cancer; 1989 May; 59(5):775-82. PubMed ID: 2736212
[TBL] [Abstract][Full Text] [Related]
2. Natural history of human breast cancer: recent data and clinical implications.
Tubiana M; Koscielny S
Breast Cancer Res Treat; 1991 Aug; 18(3):125-40. PubMed ID: 1756255
[TBL] [Abstract][Full Text] [Related]
3. [Natural history of human cancer and prognostic factors. The example of breast cancer].
Tubiana M; Koscielny S
Bull Cancer; 1987; 74(1):43-57. PubMed ID: 3567387
[TBL] [Abstract][Full Text] [Related]
4. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
5. The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.
Sopik V; Narod SA
Breast Cancer Res Treat; 2018 Aug; 170(3):647-656. PubMed ID: 29693227
[TBL] [Abstract][Full Text] [Related]
6. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
7. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
8. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
9. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
Laura S; Coombs NJ; Ung O; Boyages J
ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
[TBL] [Abstract][Full Text] [Related]
10. [Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by "sentinel node" detection?].
Reuhl T; Kaisers H; Markwardt J; Haensch W; Hohenberger P; Schlag PM
Dtsch Med Wochenschr; 1998 May; 123(19):583-7. PubMed ID: 9618639
[TBL] [Abstract][Full Text] [Related]
11. Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer.
Cserni G; Burzykowski T; Vinh-Hung V; Kocsis L; Boross G; Sinkó M; Tarján M; Bori R; Rajtár M; Tekle E; Maráz R; Baltás B; Svébis M
Jpn J Clin Oncol; 2004 Sep; 34(9):519-24. PubMed ID: 15466825
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.
Gajdos C; Tartter PI; Bleiweiss IJ
Ann Surg; 1999 Nov; 230(5):692-6. PubMed ID: 10561094
[TBL] [Abstract][Full Text] [Related]
13. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
14. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
[TBL] [Abstract][Full Text] [Related]
15. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
16. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
[TBL] [Abstract][Full Text] [Related]
17. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
[TBL] [Abstract][Full Text] [Related]
18. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.
Janni W; Rack B; Sommer H; Schmidt M; Strobl B; Rjosk D; Klanner E; Thieleke W; Gerber B; Friese K; Dimpfl T
J Cancer Res Clin Oncol; 2003 Sep; 129(9):503-10. PubMed ID: 12884027
[TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
20. Histology in breast cancer prognosis.
Champion HR; Wallace IW; Prescott RJ
Br J Cancer; 1972 Apr; 26(2):129-38. PubMed ID: 4114100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
